chronic
rhinosinus
cr
multifactori
condit
microbiota
play
pathogen
role
natur
interact
microbiota
local
immun
system
complex
fulli
elucid
recent
improv
microbiolog
techniqu
greatli
advanc
understand
complex
natur
interact
paper
summar
current
state
rapidli
evolv
research
subject
defin
natur
role
microbiota
cr
import
associ
therapeut
implic
complex
microbi
commun
coevolv
speci
one
time
individu
host
trillion
microorgan
outnumb
human
cell
least
factor
bacteri
commun
demonstr
mucosa
entir
respiratori
tract
highest
concentr
found
upper
respiratori
tract
urt
addit
bacteria
polymeras
chain
reaction
pcr
base
studi
reveal
presenc
viral
pathogen
urt
evid
presenc
fungi
healthi
sinu
mucosa
interact
microorgan
microorgan
mucosa
environment
chang
influenc
composit
bacteri
ecosystem
greater
mucos
biodivers
may
play
vital
role
limit
inflamm
protect
infect
recent
evid
mucos
inflamm
paranas
sinus
associ
decreas
divers
local
bacteri
commun
particular
microbi
speci
known
keyston
speci
may
except
larg
impact
ecosystem
function
health
dolosigranulum
spp
corynebacterium
spp
two
exampl
urt
microbiota
signific
advanc
sequenc
technolog
past
decad
chang
perceiv
structur
function
microbi
commun
start
understand
role
microbiom
play
set
sinonas
inflamm
articl
summar
current
understand
role
microbiom
chronic
rhinosinus
term
microbiota
describ
assemblag
microorgan
present
defin
environ
microbiom
refer
collect
gene
encod
member
microbiota
upper
respiratori
tract
ecosystem
creat
bacteri
viral
fungal
speci
interact
mucos
immun
system
tradit
culturedepend
techniqu
involv
sampl
surfac
sinonas
mucosa
grow
microb
growth
media
techniqu
often
captur
entir
microbi
divers
sampl
cultur
media
may
provid
condit
requir
growth
mani
organ
present
tradit
techniqu
still
sensit
less
expens
allow
vitro
determin
antibiot
sensit
pathogen
newer
cultureindepend
molecular
method
includ
immunolog
nucleicacid
base
genetarget
metaom
techniqu
techniqu
allow
identif
microorgan
sampl
without
requir
growth
vitro
even
nonviabl
immunolog
techniqu
includ
elisa
serolog
assay
microarray
test
moder
level
sensit
moder
level
specif
advantag
quick
rel
inexpens
disadvantag
includ
limit
detect
microorgan
low
abund
technic
difficulti
gener
highli
select
antibodi
nucleic
acidbas
test
hybrid
pcr
sequenc
dnarna
e
microarray
excel
specif
advantag
provid
detail
unbias
inform
potenti
reveal
novel
organ
genetarget
metaom
two
type
molecular
techniqu
potenti
allow
detail
analysi
microbiom
paranas
sinus
rrna
gene
bacteria
rrna
gene
fungi
commonli
target
gene
metaom
amplifi
specif
target
gene
sampl
sequenc
detect
total
dna
rna
protein
content
sampl
reveal
inform
function
themicrobiom
sampl
chronic
rhinosinus
cr
inflammatori
disord
upper
airway
affect
approxim
western
popul
pathophysiolog
condit
still
poorli
understood
multipl
environment
host
microbi
factor
implic
put
patholog
factor
includ
chang
microbiota
imbal
local
system
immun
system
allergen
toxin
genet
predisposit
role
microbiom
pathogenesi
cr
renew
interest
due
improv
diagnost
techniqu
presenc
intramucos
bacteria
biofilm
dysbiosi
microbiom
super
antigen
suggest
play
role
pathogenesi
cr
presenc
bacteria
healthi
sinus
demonstr
correct
earlier
assert
sinu
mucosa
steril
newer
molecular
techniqu
shown
rich
complex
bacteri
commun
includ
anaerob
organ
healthi
paranas
sinus
germ
free
murin
model
use
show
acquir
sinu
microbiom
alter
matur
mucosa
colon
mucos
surfac
occur
earli
infanc
composit
microbiom
typic
stabil
three
year
age
surprisingli
total
amount
bacteria
present
healthi
diseas
sinus
appear
similar
adult
determin
pcr
studi
commonli
identifi
bacteri
genera
includ
staphylococcu
corynebacterium
propionibacterium
studi
also
shown
microbiom
health
cr
show
high
interindividu
variat
pathogen
organ
typic
found
low
abund
healthi
sinus
e
may
either
transient
perman
compon
healthi
sinu
microbiom
similar
strain
aureu
seen
health
diseas
mucosa
recent
studi
explain
possibl
mechan
concentr
organ
may
predispos
inflamm
low
concentr
aureu
induc
antiinflammatori
cytokin
howev
high
concentr
favor
reduct
lead
pro
inflammatori
respons
commonli
identifi
propionibacterium
acn
healthi
mucosa
shown
produc
bacteriocin
act
antimicrobi
antifung
compound
modul
immun
respons
pathogen
bacteria
like
microorgan
protect
make
difficult
pathogen
speci
becom
establish
passiv
compet
space
nutrient
along
activ
secret
antimicrobi
compound
number
studi
attempt
identifi
link
cr
specif
bacteria
aureu
streptococcu
sp
corynebacterium
sp
epidermidi
p
acn
frequent
cultur
cr
patient
h
influenza
e
coli
peptostreptococcu
sp
klebsiella
sp
fusobacterium
also
seen
lower
abund
howev
except
aureu
associ
singl
speci
cr
tenuou
suggest
cr
result
presenc
singl
speci
rather
chang
composit
function
microbi
commun
recent
perform
metaanalysi
studi
compar
composit
bacteri
microbiom
cr
patient
compar
healthi
control
found
signific
differ
speci
composit
howev
microbiom
cr
patient
found
reduc
divers
increas
bacteri
load
less
stabl
bacteri
network
imbal
dysbiosi
microbiom
may
potenti
caus
sinonas
inflamm
studi
shown
propionobacterium
acn
act
key
bacteri
speci
network
creat
divers
bacteri
commun
healthi
sinu
mucosa
thu
remov
speci
may
result
fragment
commun
allow
potenti
pathogen
organ
staphylococcu
streptococcu
flourish
commun
disrupt
propos
one
mani
caus
contribut
recalcitr
cr
symbiosi
microbi
ecosystem
allow
effici
nutrient
transport
resourc
use
result
decreas
pathogen
colon
accordingli
chang
divers
coloni
may
favor
pathogen
organ
biofilm
special
commun
adher
microorgan
surround
three
dimension
structur
extracellular
matrix
multipl
bacteri
fungal
speci
live
singl
biofilm
biofilm
also
allow
organ
metabol
cooper
enhanc
effici
quorum
sens
system
control
growth
enlarg
gene
pool
effect
dna
share
capabl
bacteri
biofilm
detect
sinu
mucosa
cr
patient
common
speci
identifi
biofilm
includ
aureu
pneumonia
p
aeruginosa
h
influenza
acinetobact
spp
proteu
mirabili
enterobact
spp
coagulas
neg
staphylococci
biofilm
also
seen
healthi
sinu
mucosa
presenc
impli
caus
mucos
inflamm
howev
context
cr
sever
possibl
mechan
biofilm
may
proinflammatori
includ
releas
plankton
organ
product
superantigen
caus
ciliari
dysfunct
inhibit
mucociliari
clearanc
intraepitheli
microorgan
also
identifi
cr
patient
includ
aureu
microcoloni
also
identifi
interstitium
epitheli
layer
coloni
initi
host
immun
respons
may
act
sourc
ongo
inflamm
follow
medic
surgic
treatment
like
factor
combin
host
immun
system
respons
disrupt
epitheli
line
play
role
pathogenesi
cr
medic
treatment
cr
includ
antibiot
system
topic
corticosteroid
salin
lavag
small
number
studi
examin
chang
microbiom
antibiot
medic
treatment
one
studi
show
respons
follow
antibiot
treatment
far
consist
although
overal
small
loss
divers
colon
taxa
less
suscept
prescrib
antibiot
also
observ
studi
sought
determin
effect
topic
salin
budesonid
chronic
rhinosinus
nasal
polyposi
crswnp
healthi
patient
observ
notabl
chang
microbiom
crswnp
cohort
crosssect
studi
look
factor
influenc
microbiom
cr
patient
found
antibiot
use
reduc
divers
increas
abund
aureu
like
antibiot
may
posit
neg
effect
outcom
cr
singl
cours
oral
antibiot
shown
alter
gastrointestin
microbiom
two
year
conceiv
alter
sinonas
microbiom
antibiot
could
unfavor
alter
clinic
cours
cr
indirect
evid
support
supposit
impact
surgeri
sinonas
microbiom
investig
small
number
studi
composit
microbiom
patient
cr
undergo
surgeri
control
undergo
transsphenoid
pituitari
surgeri
compar
baselin
acinetobact
spp
higher
abund
patient
without
cr
aureu
much
lower
abund
interestingli
patient
respond
well
sinu
surgeri
acinetobact
spp
level
increas
compar
amount
control
group
particular
acinetobact
johnsonii
associ
significantli
improv
symptom
control
follow
surgeri
organ
known
elabor
import
antiinflammatori
cytokin
previous
mention
import
acinetobact
also
seen
studi
atop
dermat
anoth
studi
shown
similar
chang
microbiom
cr
patient
fess
note
studi
report
increas
staphylococcu
spp
despit
use
antistaphylococc
antibiot
immedi
postop
increas
aureu
also
shown
associ
reduc
bacteri
divers
higher
revis
surgeri
rate
recalcitr
diseas
grow
evid
surgeri
medic
intervent
alter
microbiom
sinu
caviti
like
certain
commens
speci
acinetobact
may
help
encourag
microbi
commun
stabil
resist
establish
pathogen
speci
hypothes
manipul
sinu
microbiom
may
favor
alter
cours
cr
probiot
propos
improv
inhibit
pathogen
organ
augment
epitheli
barrier
studi
shown
topic
nasal
administr
probiot
reduc
sinu
inflamm
caus
pathogen
bacteria
mous
model
anoth
murin
studi
also
show
pretreat
epidermidi
might
reduc
inflammatori
effect
aureu
nasal
mucosa
oral
probiot
use
cr
assess
sever
studi
use
oral
enterococcu
faecali
show
benefit
treat
cr
recurr
acut
rhinosinus
two
studi
benefit
seen
last
month
one
random
studi
probiot
administ
month
although
use
probiot
well
describ
gastrointestin
research
use
cr
remain
limit
larg
number
dna
virus
singlestrand
rna
virus
bacteriophag
detect
healthi
adult
sever
studi
shown
varieti
abund
virus
cr
includ
coronaviru
viru
replic
damag
mucos
line
increas
bacteri
adhes
mucosa
factor
may
play
role
pathogenesi
cr
techniqu
identifi
organ
improv
along
better
understand
identif
taxa
better
understand
sinonas
virom
develop
sever
molecular
base
studi
determin
mycobiom
sinu
mucosa
cryptococcu
neoforman
aspergillu
speci
malassezia
speci
identifi
cr
mucosa
malassezia
also
seen
healthi
sinu
mucosa
newer
target
sequenc
approach
detect
fungi
often
healthi
inflam
sinu
mucosa
prior
research
also
shown
fungi
interact
aureu
p
aeruginosa
sinonas
mucosa
fungi
may
act
synergist
pathogen
bacteri
coloni
play
role
pathogenesi
cr
understand
microorgan
paranas
sinu
still
incomplet
although
associ
viral
fungal
bacteri
organ
cr
exact
natur
import
relationship
still
unclear
role
play
microbiom
cr
difficult
clearli
defin
current
time
due
difficulti
laboratori
techniqu
small
studi
limit
sampl
size
larger
longitudin
multilevel
studi
design
role
microbiom
cr
role
specif
treatment
probiot
mucu
transplant
would
becom
clear
rapid
progress
also
made
laboratori
techniqu
enabl
determin
composit
sinonas
microbiom
cr
hope
result
current
investig
soon
inform
antibiot
probiot
surgic
treatment
rahuram
sivasubramaniam
richard
dougla
declar
actual
potenti
conflict
interest
